Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Therapeuticsmd Inc (NQ: TXMD ) 1.730 +0.220 (+14.57%) Streaming Delayed Price Updated: 3:51 PM EDT, Jul 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 32,512 Open 1.500 Bid (Size) 1.700 (6) Ask (Size) 1.750 (2) Prev. Close 1.510 Today's Range 1.477 - 1.730 52wk Range 1.430 - 4.350 Shares Outstanding 9,953,290 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News TXMD Stock Earnings: TherapeuticsMD Reported Results for Q4 2023 June 28, 2024 TherapeuticsMD just reported results for the fourth quarter of 2023. Via InvestorPlace TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024 May 10, 2024 TherapeuticsMD just reported results for the first quarter of 2024. Via InvestorPlace Performance YTD -25.75% -25.75% 1 Month -17.62% -17.62% 3 Month -19.91% -19.91% 6 Month -26.69% -26.69% 1 Year -56.20% -56.20% More News Read More TherapeuticsMD Announces First Quarter 2024 Financial Results May 10, 2024 From TherapeuticsMD, Inc. Via Business Wire TherapeuticsMD Announces Full Year 2023 Financial Results March 29, 2024 From TherapeuticsMD, Inc. Via Business Wire 5 Value Stocks In The Healthcare Sector March 04, 2024 Via Benzinga Overview Of Value Stocks In The Healthcare Sector February 12, 2024 Via Benzinga Overview Of Value Stocks In The Healthcare Sector June 05, 2023 Via Benzinga A Look Into Healthcare Sector Value Stocks December 25, 2023 Via Benzinga Overview Of Value Stocks In The Healthcare Sector November 27, 2023 Via Benzinga TherapeuticsMD Announces Third Quarter 2023 Financial Results November 14, 2023 From TherapeuticsMD, Inc. Via Business Wire Nasdaq Jumps 100 Points; US Trade Deficit Widens In September November 07, 2023 Via Benzinga Topics Stocks Exposures US Equities TherapeuticsMD Announces Second Quarter 2023 Financial Results August 14, 2023 From TherapeuticsMD, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Thursday September 21, 2023 Via Benzinga TherapeuticsMD Announces First Quarter 2023 Financial Results May 15, 2023 From TherapeuticsMD, Inc. Via Business Wire TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition April 07, 2023 From TherapeuticsMD, Inc. Via Business Wire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday January 23, 2023 Via InvestorPlace TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma January 03, 2023 From TherapeuticsMD, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's After-Market Session January 02, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session December 05, 2022 Via Benzinga TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma December 04, 2022 From TherapeuticsMD, Inc. Via Business Wire TherapeuticsMD Announces Third Quarter 2022 Financial Results November 14, 2022 From TherapeuticsMD, Inc. Via Business Wire TherapeuticsMD Announces Additional $7 Million Private Placement October 31, 2022 From TherapeuticsMD, Inc. Via Business Wire TherapeuticsMD Announces $7 Million Private Placement October 03, 2022 From TherapeuticsMD, Inc. Via Business Wire 12 Health Care Stocks Moving In Tuesday's After-Market Session September 27, 2022 Via Benzinga TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers September 12, 2022 From TherapeuticsMD, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
